Advertisement

Topics

Latest "Auris Medical Announces Closing Million Public Offering" News Stories

05:05 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Auris Medical Announces Closing Million Public Offering" found in our extensive news archives from over 250 global news sources.

More Information about Auris Medical Announces Closing Million Public Offering on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Auris Medical Announces Closing Million Public Offering for you to read. Along with our medical data and news we also list Auris Medical Announces Closing Million Public Offering Clinical Trials, which are updated daily. BioPortfolio also has a large database of Auris Medical Announces Closing Million Public Offering Companies for you to search.

Showing "Auris Medical Announces Closing Million Public Offering" News Articles 1–25 of 43,000+

Saturday 23rd March 2019

Abbisko Completes $42 Million Series B Funding for Oncology Candidates

Abbisko Therapeutics of Shanghai completed a $42 million series B fundraising led by new investor Qiming, which it will use to start clinical trials of its oncology molecules and expand its discovery pipeline. Later this year, the company expects to start Phase I trials of its two lead candidates, a small molecule FGFR4 inhibitor for hepatocellular carcinoma (HCC) and a CSF1R inhibitor for solid t...


Friday 22nd March 2019

[Correspondence] Keeping promises to women, children, and adolescents

By 2015, at the end of the Millennium Development Goals (MDGs) era, each year more than 6 million children younger than 5 years and 1 million adolescents were dying each year and more than 300 000 maternal deaths were occurring every year.1 These deaths are a substantial health problem and social injustice because most cases are preventable and are concentrated in rural populations and poorer co...

UnitedHealthcare and Optum Take Action to Support People Affected by Flooding in Missouri and Kansas

Assistance for UnitedHealthcare plan participants whose access to care or prescriptions needs may have been affected Free emotional-support help line from Optum open to anyone UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affect...


AAHRPP Accredits Three More Research Organizations

Two in the U.S., one in Taiwan attain the gold standard WASHINGTON, March 22, 2019 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs today announced its first accreditations for 2019: a research institute in Massachusetts, a health care delivery system in California and a hospital in Taiwan. The three newly accredited organiza...

Shaggy, Big Freedia Headline Saturday’s Florida AIDS Walk & Music Festival, on Track to Raise $1.5M

AHF’s 14th annual Florida AIDS Walk and Music Festival on March 23rd and set to nearly $1.5 million, will benefit 10 non-profits that provide HIV/AIDS services in South Florida, the nation’s epicenter for HIV. Multi Grammy award-winning, reggae artist Shaggy and the Queen of bounce music, Big Freedia will join an array of performers over the spring...

American Oncology Network, LLC (AON) Introduces Specialty Oral Oncolytic Pharmacy

Community Oncology Patients Benefit from AON In-House Pharmacy Services The American Oncology Network, LLC (AON), an alliance of physicians and seasoned healthcare leaders, provides a unique array of support services to its affiliated community-based oncology practices, including in-house specialty pharmacy services. The AON Pharmacy streamlines the pr...

Healthcare Special Opportunities Fund Announces March 2019 Quarterly Distribution

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 22, 2019 (GLOBE NEWSWIRE) — (TSX: MDS.UN) – LDIC Inc. (the “Manager”), the manager of Healthcare Special Opportunities Fund (the “Fund”), a closed-end investment … Continue reading →

Navidea Biopharmaceuticals Announces Stock Purchase Agreement; Other Business Updates

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced execution of a Stock Purchase Agreement (the “Purchase Agreement”) with an existing investor, John K. Scott, Jr. (the “Investor”), pursuant to ...

At #CGDay19, panelists say the ability of cell and #genetherapy companies to raise capital hinges on how well they address #manufacturing and address medical needs beyond #Cancer: http://ow.ly/M9UN30o9qYS 

At #CGDay19, panelists say the ability of cell and #genetherapy companies to raise capital hinges on how well they address #manufacturing and address medical needs beyond #Cancer: http://ow.ly/M9UN30o9qYS 

WuXi AppTec Reports Strong 2018 Annual Results

Revenue RMB9,614 Million, up 23.8% (25.4% at Constant Exchange Rate) Year-Over-Year Net Profit Attributable to Owners of the Company RMB2,261 Million, up 84.2% Year-Over-Year Diluted EPS RMB 2.21, up 70.0% Year-Over-Year SHANGHAI, March 22, 2019 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 0235...

FDA Approves Ketamine Derivative as Depression Treatment for First Time

Treatment-resistant depression affects 1 in 3 of the estimated 16.2 million adults in the U.S. who have suffered at least one major depressive episode. For them, two or more therapies have failed and the risk of suicide is much greater. It’s a grim prognosis. There are few therapies for depression that resists treatment, which is why the FDA granted this new drug application Fast Track and Brea...

Society for Immunotherapy of Cancer Announces 2019 Recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship

The Society for Immunotherapy of Cancer (SITC) is pleased to announce Olivera J. Finn, PhD, University of Pittsburgh Distinguished Professor of Immunology and Surgery and Founding Chair of the university’s Department of Immunology, as the 2019 recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship, the society’s highest honor. MILWAUKEE (PRWEB) March 22, 2019 The Society for ...

Kadmon Holdings, Inc.: Kadmon Announces Susan Wiviott to Step Down from Board of Directors

NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Susan Wiviott does not intend to stand for re-election to Kadmon's Board of Directors at the upc...

FitLife Brands Announces 2018 Results

FitLife Brands, Inc. (“FitLife”) (OTC Pink: FTLF), an international provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition Products™ ("NDS") (www.ndsnutrition.com), PMD® (www.pmdsports.com), SirenLabs® (

Physicians Realty Trust Declares Quarterly Cash Dividend and Announces Date for First Quarter 2019 Earnings Release and Conference Call

Physicians Realty Trust (NYSE:DOC) (the “Company”) announced today that the Company’s Board of Trustees has authorized and the Company has declared a quarterly cash dividend of $0.23 per common share and unit for the quarter ending March 31, 2019. “We are proud to declare and pay our 23rd consecutive quarterly dividend. Medical office cont...

Gossamer Bio Announces 2018 Annual Financial Results

Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the year ended December 31, 2018 and provided an update on recent corporate developments. ...

Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in ...

Titan Medical nets $26.7mm via public offering

Titan Medical Inc. (robotic system for minimally invasive surgery) grossed $26.7mm through the overnight marketed offering of...

Retailers dedicate resources to Midwest flood recovery

U.S. Customs details China pork seizure; importers could pay fine

U.S. border agents said they have seized 1 million pounds (453,592 kg) of food products from China this month, rather than 1 million pounds of pork as they had previously announced, as they work to keep out African swine fever.

Nashville-based Change Healthcare files for $100 million IPO

The company is currently owned by joint venture consisting of McKesson – which owns around 70 percent of the company – and private equity firms Blackstone and Hellman & Friedman.

FDA Turns Down Sotagliflozin for Type 1 Diabetes

Advisory panel had expressed major concerns about diabetic ketoacidosis. Medscape Medical News

Hikma launches Levophed generic

'Surprise' Medical Bills: Easy to Define, But Not to Solve

(MedPage Today) -- Patients must be removed from the equation, experts agree

Tesaro's On The Right Path With Anti-PD-1 Dostarlimab In Endometrial Cancer

Interview: Tesaro Chief Medical Officer Martin Huber addresses dostarlimab GARNET data and provides an update on integration with GlaxoSmithKline.   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks